We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Accrol Group Holdings Plc | LSE:ACRL | London | Ordinary Share | GB00BZ6VT592 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.05 | 0.13% | 38.55 | 38.50 | 38.60 | 38.90 | 38.50 | 38.60 | 3,523,917 | 16:35:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Convrt Paper,paperbd Pds,nec | 241.91M | -5.7M | -0.0179 | -21.51 | 122.77M |
TIDMACRL
RNS Number : 6087D
Accrol Group Holdings PLC
04 March 2022
4 March 2022
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.
Accrol Group Holdings plc
("Accrol" or the "Company")
Director Dealing
Accrol (AIM:ACRL), the UK's leading independent tissue convertor, announces that Dan Wright, Executive Chairman of Accrol, has purchased 1,000,000 ordinary shares of GBP0.001 each ("Ordinary Shares") at an average price of 19.5875p per Ordinary Share.
Following this purchase, he now holds 12,515,543* Ordinary Shares representing approximately 3.9% of the current Issued Share Capital of the Company.
* 10,786,972 of these shares are registered in the name of Gomrath Limited, a family investment company controlled by Dan Wright
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Details of the person discharging managerial 1 responsibilities / person closely associated a) Name Dan Wright ---------------------- ---------------------------- 2 Reason for the notification ---------------------------------------------------- a) Position/status Executive Chairman ---------------------- ---------------------------- b) Initial notification Initial notification /Amendment ---------------------- ---------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ---------------------------------------------------- a) Name Accrol Group Holdings plc ---------------------- ---------------------------- b) LEI 213800MC56M5G69RJ226 ---------------------- ---------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ---------------------------------------------------- a) Description Ordinary shares of GBP0.001 of the financial each instrument, type of instrument Identification code ISIN: GB00BZ6VT592 ---------------------- ---------------------------- b) Nature of Purchase of Ordinary Shares the transaction ---------------------- ---------------------------- c) Price(s) and Price(s) Volume(s) volume(s) 1 9.5p 750,000 19.85p 250,000 ---------- ---------------------- ---------------------------- Aggregated d) information - Aggregated volume 1,000,000 - Price 19.5875p --------------------------- ---------------------------- e) Date of the 3 March 2022 transaction ---------------------- ---------------------------- f) Place of the London Stock Exchange, AIM transaction ---------------------- ---------------------------- For further information, please contact: Accrol Group Holdings plc Dan Wright, Executive Chairman Via Belvedere Communications Gareth Jenkins, Chief Executive Officer Richard Newman, Chief Financial Officer Zeus Capital Limited (Nominated Adviser & Broker) Dan Bate / Jordan Warburton Tel: +44 (0) 161 831 1512 Dominic King Tel: +44 (0) 203 829 5000 Liberum Capital Limited (Joint Broker) Tel: +44 (0) 20 3100 2222 Clayton Bush / Edward Thomas Belvedere Communications Limited Cat Valentine Tel: +44 (0) 7715 769 078 Keeley Clarke Tel: +44 (0) 7967 816 525 Llew Angus Tel: +44 (0) 7407 023 147 accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate revenues totalling c.16% of the GBP2.1bn UK retail tissue market.
For more information, please visit www.accrol.co.uk
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHFLFITVDIVIIF
(END) Dow Jones Newswires
March 04, 2022 02:00 ET (07:00 GMT)
1 Year Accrol Chart |
1 Month Accrol Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions